Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that Stefan Zeuzem, M.D., has joined the company as Chair of the Scientific and Clinical Advisory Board.  Dr. Zeuzem will...

LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

CENTENNIAL, Colo. and ALISO VIEJO, Calif., March 15, 2011 /- LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry...

Nottingham University Hospital is First U.K. User of Elekta's Electronic Medical Record Workspace for Image Guided Radiation Therapy

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

NOTTINGHAM, England, March 15, 2011 /- Delivering Image Guided Radiation Therapy (IGRT) effectively and safely involves careful coordination of sophisticated systems, such as the therapy machine and its imaging subsystems, as well as the electronic medical record (EMR) used to schedule...

Advertisement

Oconee Medical Center is Winner of Siemens 'Who Inspires You?' Video Contest

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, March 15, 2011 /- Oconee Medical Center in Seneca, S.C., is the winner of Siemens "Who Inspires You?" video contest and the recipient of a new MAMMOMAT® Inspiration, Siemens next generation full-field digital mammography system. (Photo:...

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical Inc. (OTC Bulletin Board: ONCSD ), a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. (NYSE Amex:...

Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., March 15, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. (OTC Bulletin Board:...

OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical, Inc. (OTC Bulletin Board: ONCSD ) announced today that Mr. Punit Dhillon, President and CEO, will present a company overview on Wednesday, March 16 at 2:00 pm PT at the ROTH 23rd Annual Growth Stock Conference being held at the Ritz-Carlton,...

ARMSRx and 84 Lumber Hammer Down Rx Costs...Again

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

EIGHTY FOUR, Pa., March 15, 2011 /- ARMSRx Pharmacy Benefit Consulting, the nation's leading Pharmacy Benefit consulting firm, has consistently provided successful recommendations for their clients. On February 16th, ARMSRx presented results to one of their premier clients, 84 Lumber....

Advertisement

Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017...

Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

Reportlinker Adds Insulin Lispro - Comprehensive Patent Search

March 14, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Insulin Lispro - Comprehensive patent search http://www.reportlinker.com/p0447411/Insulin-Lispro----Comprehensive-patent-search.html Eliminate unnecessary risk with the...

Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer

March 14, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, March 14, 2011 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a market leading provider of document workflow solutions for hospitals, announced today that Rick Leach has been appointed Senior Vice President and Chief Marketing Officer effective March 14, 2011. With more...

FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium

March 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., March. 14, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a...

Advertisement

LaVoie Group Wins Two Mercury Excellence Awards

March 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

SALEM, Mass., March 14, 2011 /- LaVoie Group, the acknowledged leader in life science and pharmaceutical communications, announced today that it has received a Gold Award in the 24th Annual International Mercury Excellence Awards 2010/2011 competition, given annually by MerComm, Inc....

Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology

March 14, 2011 12:32 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., March 14, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB (formerly Tripep AB), has initiated a Phase...

Medical Imaging Taps New Levels of Graphics Display Technologies

March 11, 2011 9:34 am | by Nancy Pantone and Christine A. Van De Graaf | Articles | Comments

A major growth area in medical device technology, medical imaging is gaining momentum in the number of clinical applications for which it’s being prescribed. Now, new COM Express technology enables multi-display functionality for healthcare applications. This article reviews the new technology.

Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. and LONDON, March 11, 2011 /- Tolerx, Inc. and GlaxoSmithKline (GSK) today announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12...

Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 11, 2011 /- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the...

Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 11, 2011 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments. "Our focus is working with Eisai to obtain FDA approval of lorcaserin, preparing to...

Qforma Appoints Two New Executives

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SANTA FE, N.M., March 11, 2011 /- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of Elna Hamp to Vice President, Business Development and Joann Flynn to Marketing Manager. "As our clients' business models continue to evolve with the...

Dendreon Expands Launch of PROVENGE

March 10, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

SEATTLE, March 10, 2011 /- Dendreon Corporation (Nasdaq: DNDN ) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey manufacturing facility, allowing the company to significantly increase the availability of PROVENGE®...

InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing

March 10, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, March 10, 2011 /- InstaCare Corp. (OTC Bulletin Board: ISCR ), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent...

MPO Symposium Offers Medical Device Manufacturers the Opportunity to Tour Plants in Costa Rica

March 10, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

RAMSEY, N.J., March 10, 2011 /- As part of a two-day education and networking event, MPO Symposium provides medical device manufacturers rare access to local facilities in and around San Jose, Costa Rica, following a morning of conference sessions on May 11. As part of your conference...

Remedi SeniorCare Expands Distribution of the Paxitâ„¢ Med-Pass Solution, the New Standard in Medication Administration

March 10, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, March 10, 2011 /- Remedi SeniorCare®, which is among the nation's largest independent institutional pharmacies, is revolutionizing the long-term care (LTC) pharmacy industry with the Paxit™ med-pass system, its 24-hour unit dose medication administration system...

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease

March 10, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

WAYLAND, Mass., March 10, 2011 /- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading